glp 1 drugs and blindness π Optometrists are warning GLP-1 may pose these types of rare risks π β¬οΈ Details in comments Exploring the Side Effects of
Description
Current Molecular Pharmacology
When food enters the small intestine, GLP-1 is released, stimulating the pancreas to secrete insulin, the hormone responsible for lowering blood sugar

doi: 10.1007/s12020-019-02055-z 93 PintoLCFalcettaMRRadosDVLeitaoCBGrossJL
Additional file 1: Fig
TSA confirmed that enough patients were randomized and again no association of the medications and pancreatic cancer was observed considering a NNH of 1000 and the short mean follow-up of the included trials (1.7 years)

Disulfide cross-linking validates the physiological relevance of the closed conformation, while electron microscopy (EM) and molecular dynamic (MD) simulations suggest a large degree of conformational dynamics of ECD that is necessary for binding GLP-1
